{"id":408,"date":"2026-09-03T10:00:00","date_gmt":"2026-09-03T01:00:00","guid":{"rendered":"https:\/\/engitissuedesign.com\/?p=408"},"modified":"2026-09-28T15:29:25","modified_gmt":"2026-09-28T06:29:25","slug":"engitissue-design-gave-an-oral-presentation-at-isct-asia-2026-international-society-for-cell-gene-therapy","status":"publish","type":"post","link":"https:\/\/engitissuedesign.com\/en\/engitissue-design-gave-an-oral-presentation-at-isct-asia-2026-international-society-for-cell-gene-therapy\/","title":{"rendered":"EngiTissue Design Gave an Oral Presentation at ISCT Asia 2026 (International Society for Cell & Gene Therapy)"},"content":{"rendered":"

On September 3, 2026, EngiTissue Design Co., Ltd. participated in the ISCT Asia 2026 Regional Meeting (International Society for Cell & Gene Therapy), held at the Suntec Singapore Convention & Exhibition Centre in Singapore.<\/p>\n

At the meeting, an abstract by Li Junjun of our company was accepted for an Oral Presentation and delivered in Oral Session 2.<\/p>\n

Presentation title: A dual excitation-contraction platform for functional evaluation and drug safety assessment of human iPSC-derived cardiac tissues<\/p>\n

In the presentation, using human iPSC (induced pluripotent stem cell)-derived cardiac tissue, we reported a platform for evaluating tissue function and applying it to drug safety assessment. A poster presentation was also given, and we held active discussions with fellow researchers and experts.<\/p>\n

EngiTissue Design continues to develop functional and drug-safety evaluation technologies utilizing iPSC-derived tissues. We will keep sharing our research results and building a global network through such international academic exchanges.<\/p>\n\n

\n\n
\"ISCT<\/figure>\n\n\n
\"ISCT<\/figure>\n\n\n
\"ISCT<\/figure>\n\n\n
\"ISCT<\/figure>\n\n\n
\"ISCT<\/figure>\n\n<\/figure>\n\n

Related Publications<\/h2>\n